Podcasts about Breast cancer

SEND US A TEXT MESSAGE!!! Let Drs. Nii & Renee know what you think about the show!We start off by discussing medical myths/traditions we should retire. We then talk about MTV personality Ananda Lewis, who died at age 52 from breast cancer after rejecting medical treatment in favor of detoxification.We dive deep into why patients have lost trust in healthcare providers and how the  medical credibility gap has widened dramatically in recent years. We conclude with Nii showing us his running equipment. FREE DOWNLOAD -  7 Considerations Before Starting Locum Tenens - https://darkos.lpages.co/7-considerations-before-locumsLINKS MENTIONED Q&A and Suggestions Form - https://forms.clickup.com/9010110533/f/8cgpr25-4614/PEBFZN5LA6FKEIXTWFSend us a Voice Message - https://www.speakpipe.com/docsoutsidetheboxSIGN UP FOR OUR NEWSLETTER! WATCH THIS EPISODE ON YOUTUBE!Have a question for the podcast?Text us at 833-230-2860Twitter: @drniidarkoInstagram: @docsoutsidetheboxEmail: team@drniidarko.comMerch: https://docs-outside-the-box.creator-spring.comThis episode is sponsored by Set For Life Insurance. What the Darkos use for great disability insurance at a low cost!! Check them out at www.setforlifeinsurance.com

If you've ever found yourself hurt, frustrated, or emotionally drained because someone didn't do what you thought they should—especially after you asked—this episode is for you. In this conversation, I'm talking about a powerful concept I use with my clients all the time, called “the manual.” It's the invisible rulebook we write in our minds about how other people should behave and what their actions (or lack of action) mean about us. But here's the catch: no one else has a copy of that manual. And when people don't follow our unspoken rules, we end up making it mean something painful—like “they don't care,” or “they don't love me.” That pain builds up, and it affects our emotional and physical health, especially when we're healing after something as life-changing as breast cancer. So in this episode, I'm sharing how to spot when you're living by a manual, how to burn it, and how to replace it with something far more powerful: clear, loving boundaries that support your peace and your healing.  

Physician Within Heal Thyself  Have you met your Physician- Within yet? Our Precognitive Dreams and Nightmares can deal with medical information, be Pearls of Wisdom, and be part of the ancient concept of “Physician Within Heal Thyself.” During this episode of Dreaming Healing, author and three-time Breast Cancer survivor Kat  Kanavos, aka The Queen of Dreams, discusses her Physician-Within, who introduces herself during a dream as Dr. Jules during an amazing Precognitive Diagnostic Dream. This is from Ch 25, pg 140 of her International multi award-winning book,  Surviving Cancerland: Intuitive Aspects of Healing.  BIO: Kathleen O'Keefe-Kanavos, aka Kat-The Queen of Dreams, is a three time breast cancer survivor, stage 4 recurrence, and Dream Expert who wrote the International and multi-award winning bestseller, Surviving Cancerland: Intuitive Aspects of Healing to help other people survive crisis. Her book is a path to wellness. She has shared her story on many platforms including Dr. Oz, the DOCTORS, and George Noory's, Coast to Coast AM , to name a few. Video Version: https://www.youtube.com/live/RsCvJOFO2sY?si=F4dTrEWMUXQpPiCg Chat with Kat during Live Show with Video Stream:  write a question on YouTube Have a Question for the Show? Go to Facebook– Dreams that Can Save Your Life Facebook Professional–Kathleen O'Keefe-Kanavos http://kathleenokeefekanavos.com/

Two things happened on the day I am recording this episode that make me think about how my life is different because of breast cancer.  I was doing so well not thinking about breast cancer today that I forgot to implement the usual precautions for avoiding any bug bites on my left arm. I was bitten by an ant on my left hand at the end of my walk today. Tiny ants biting seems like no big deal, but the general strategy for lymphedema prevention is to avoid impairing the integrity of the skin on the side where a lymph node dissection has been done. This includes avoiding bug bites! I know the risk of lymphedema developing in my left arm is actually very low, but I do not want to do anything that would potentially allow for breakdown in the skin on my left arm or hand.  As I was standing at the sink washing my hands after the ant incident, a flood of urine ran out of me. It left urine running down over my ankles, with visible streaks of urine on my pant legs and on the footbed of my sandals. I had no intention to sit on the toilet at this moment. What does this have to do with breast cancer life? Typically, with a pause I am able to get control of my bladder. Today was different. I cannot say for certain that I am having increased urinary urgency or incontinence because of my breast cancer treatment, but the symptoms are much worse than before I started tamoxifen in 2023. This urine flood reaffirms my recent decision to begin taking low-dose vaginal estrogen. I had discussed this option with my medical oncologist and my gynecologist last year. At the time I did not think I needed the estrogen, but after realizing the urinary side-effects I have are not getting better, I decided to get a prescription for vaginal estrogen. Without a cancer history, I would have not hesitated to add in estrogen as part of my peri-menopause or post-menopausal health care.  Breast cancer life changes everything! If you'd like to be the first to receive updates and exclusive content from the upcoming Breast Cancer Life newsletter, please email me at connect@breastcancerlife.org. I'd love to have you on the list! LET'S CONNECT: connect@breastcancerlife.org  Follow us on Pinterest   

Dr. Sujatha Kekada is the Head Physician and Co-Founder of AmrtaSiddhi Ayurvedic Clinic in Ubud, Bali. She is a certified Ayurvedic Doctor (B.A.M.S) with a degree from Rajiv Gandhi University, India. She talks with Colette about cancer with a particular focus on breast cancer and they discuss the following: Ayurveda's understanding of the root causes of breast cancer from an ama (toxins), dosha (vata, pitta and kapha), dhatu (tissue) and emotional perspective. The three ways cancer can manifest in the body. The importance of cleansing the body to prevent cancer and taking care of your breast tissue. Dr. Sujatha's approach to healing the body and mind. The role Ayurveda can play alongside allopathic treatment. Ayurveda's approach to recovery and healing after breast cancer treatment, including mastectomy or reconstruction. Preventive steps women take from an Ayurvedic perspective to maintain breast health. * Check out Dr. Sujatha's website here.... amrtasiddhi.com * Visit Colette's website www.elementshealingandwellbeing.com  Online consultations & Gift Vouchers Next discounted Group Cleanse starts October 3rd, 2025 Private at-home Digestive Reset Cleanse tailored to you Educational programs - Daily Habits for Holistic Health Have questions before you book? Book a FREE 15 min online Services Enquiry Call * Join the Elements of Ayurveda Community! * Check out the other episodes mentioned in this episode: 16 - Ayurvedic Dinacharya or Daily Routines 122 - Ayurvedic Ritucharya - Guidelines for the Seasons 244 - An Ayurvedic Digestive Reset Cleanse 263 - Ayurvedic View on the Menstrual Cycle 394 - Ayurvedic Wisdom on Exercise and Recovery Stay connected on the Elements Instagram and Facebook pages. * Enjoy discounts on your favourite Ayurvedic products: Banyan Botanicals - enter discount code ELEMENTSOFAYURVEDA at checkout for 15% off your first purchase.** Divya's  - enter discount code ELEMENTSOFAYURVEDA15 at checkout for 15% off your first purchase.** Kerala Ayurveda - enter discount code ELEMENTS15 to receive 15% off your first purchase.** LifeSpa - Save $10 on a $50 or more one-time purchase with the code elements10.  **Shipping available within the U.S. only. * Thanks for listening!  

Breast cancer is one of the most talked-about health issues in the world, but there's still so much we don't discuss. While mammograms and early detection campaigns have saved countless lives, the conversation often stops there.  What's missing is a deeper look at the lifestyle, genetic, and environmental factors that play a pivotal role in prevention, and the small, daily changes that can make a massive impact. Because here's the truth: 80% of breast cancer cases are not inherited. They're environmental. That means we have far more power than we think. But to tap into it, we need better guidance, smarter screening strategies, and a stronger understanding of how our bodies work. What kind of screenings should women get? How do factors like breast tissue increase the risk of breast cancer? In this episode, I'm joined by Dr. Pamela Smith, an internationally recognized functional medicine physician, author of 14 bestselling books, and co-director of the Personalized Medicine Certification at the University of South Florida.  She shares science-backed strategies to reduce your risk, strengthen your immune system, and support your body before and after a diagnosis. Things You'll Learn In This Episode  The 3 things that feed cancer Sugar, stress, and toxins are the trifecta that fuel cancer cell growth. But how do you realistically cut them out and what's secretly making them worse? Why 80% of breast cancer isn't genetic Family history matters but not as much as your environment. Which everyday exposures and habits have the biggest impact on your risk? The truth about hormones and alcohol Is hormone therapy safe? And what happens when you mix it with alcohol?  What most women don't know about screening Dense breast tissue, faulty methylation, even your gut health can affect your screening results. How do you make sure you're getting the full picture of your health?   Guest Bio Pamela Wartian Smith, M.D., MPH, MS is an internationally known speaker and author on the subject of Anti-Aging and Precision Medicine. She spent her first twenty years of practice as an emergency room physician with the Detroit Medical Center in a level 1 trauma center and then 28 years as an Anti-Aging/Functional Medicine specialist. She is a diplomat of the Board of the American Academy of Anti-Aging Physicians and is. Dr. Smith also holds a master's degree in public health and a master's degree in metabolic and nutritional medicine. She is in private practice and is the senior partner for The Center for Precision Medicine, with offices in Michigan and Florida. She has been featured on CNN, PBS, and many other television networks, has been interviewed in numerous consumer magazines, and has hosted two of her own radio shows. Dr. Smith was one of the featured physicians on the PBS series “The Embrace of Aging” as well as the online medical series “Awakening from Alzheimer's” and “Regain Your Brain”. She is the author of fourteen best-selling books, including How to Prevent Breast Cancer- Before & After: A Guide to Taking Back Control of Your Life. To learn more about Dr. Smith and to get her books, visit https://mdpamelasmith.com/.    About Your Host Hosted by Dr. Deepa Grandon, MD MBA, triple board-certified physician with over 23 years of experience working as a Physician Consultant for influential organizations worldwide. Dr. Grandon is the founder of Transformational Life Consulting (TLC) and an outspoken faith-based leader in evidenced-based lifestyle medicine.     ​​ Resources Feeling stuck and want guidance on how to transform your spiritual, mental and physical well being? Get access to Dr Deepa's 6 Pillars of Health video! Visit drdeepa-tlc.org to subscribe and watch the video for free. ‌ Work with Me Ready to explore a personalized wellness journey with Dr. Deepa? Visit drdeepa-tlc.org and click on “Work with Me” to schedule a free intake call. Together, we'll see if this exclusive program aligns with your needs!  Want to receive a devotional every week From Dr. Deepa? Devotionals are dedicated to providing you with a moment of reflection, inspiration, and spiritual growth each week, delivered right to your inbox. Visit https://www.drdeepa-tlc.org/devotional-opt-in to subscribe for free. Ready to deepen your understanding of trauma and kick start your healing journey? Explore a range of online and onsite courses designed to equip you with practical and affordable tools. From counselors, ministry leaders, and educators to couples, parents and individuals seeking help for themselves, there's a powerful course for everyone. Browse all the courses now to start your journey.   ​​TLC is presenting this podcast as a form of information sharing only. It is not medical advice or intended to replace the judgment of a licensed physician. TLC is not responsible for any claims related to procedures, professionals, products, or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services, or methods that might be referenced. Check out this episode on our website, Apple Podcasts, or Spotify, and don't forget to leave a review if you like what you heard. Your review feeds the algorithm so our show reaches more people. Thank you!

Dr. John Sweetenham and Dr. Erika Hamilton highlight key abstracts that were presented at ASCO25, including advances in breast and pancreatic cancers as well as remarkable data from the use of structured exercise programs in cancer care. Transcript Dr. Sweetenham: Hello, and welcome to the ASCO Daily News Podcast. I'm your host, Dr. John Sweetenham. Today, we'll be discussing some of the key advances and novel approaches in cancer care that were presented at the 2025 ASCO Annual Meeting. I'm delighted to be joined again by the chair of the Meeting's Scientific Program, Dr. Erika Hamilton. She is a medical oncologist and director of breast cancer and gynecologic cancer research at the Sarah Cannon Research Institute in Nashville, Tennessee.  Our full disclosures are available in the transcript of this episode. Dr. Hamilton, congratulations on a fantastic meeting. From the practice-changing science to the world-renowned speakers at this year's Meeting, ASCO25 really reflected the amazing progress we're seeing in oncology today and the enormous opportunities that lie ahead of us. And thanks for coming back on to the podcast today to discuss some of these advances. Dr. Hamilton: Thanks, Dr. Sweetenham. I'm happy to join you today. It really was an impactful ASCO Annual Meeting. I probably am biased, but some great research was presented this year, and I heard lots of great conversations happening while we were there. Dr. Sweetenham: Yeah, absolutely. There was a lot of buzz, as well as a lot of media buzz around the meeting this year, and I think that's probably a good place to start. So I'd like to dive into abstract number LBA3510. This was the CHALLENGE trial, which created a lot of buzz at the meeting and subsequently in the media. This is the study that was led by the NCI Canada Clinical Trials Group, which was the first randomized phase 3 trial in patients with stage III and high-risk stage II colon cancer, which demonstrated that a post-treatment structured exercise program is both feasible and effective in improving disease-free survival in this patient group. The study was performed over a long period of time and in many respects is quite remarkable. So, I wonder if you could give us your thoughts about this study and whether you think that this means that our futures are going to be full of structured exercise programs for those patients who may benefit. Dr. Hamilton: It's a fantastic question. I think that this abstract did create a lot of buzz. We were very excited when we read it. It was highlighted in one of the Clinical Science Symposium sessions. But briefly, this was a phase 3 randomized trial. It was conducted at 55 centers, so really a broad experience, and patients that had resected colon cancer who completed adjuvant therapy were allowed to participate. There were essentially 2 groups: a structured exercise program, called ‘the exercise group,' or health education materials alone, so that was called just ‘the health education group.' And this was a 3-year intervention, so very high quality. The primary end point, as you mentioned, was disease-free survival. This actually accrued from 2009 to 2024, so quite a lift, and almost 900 patients underwent randomization to the exercise group or the health education group. And at almost 8 years of follow-up, we saw that the disease-free survival was significantly longer in the exercise group than the health education group. This was essentially 80.3% of patients were disease-free in exercise and 73.9% in the health education group. So a difference of over 6 percentage points, which, you know, at least in the breast cancer world, we make decisions about whether to do chemotherapy or not based on these kind of data. We also looked at overall survival in the exercise group and health education group, and the 8-year overall survival was 90.3% in the exercise group and 83.2% in the health education group. So this was a difference of 7.1%. Still statistically significant. I think this was really a fantastic effort over more than a decade at over 50 institutions with almost 900 patients, really done in a very systematic, high-intervention way that showed a fantastic result. Absolutely generalizable for patients with colon cancer. We have hints in other cancers that this is beneficial, and frankly, for our patients for other comorbidities, such as cardiovascular, etc., I really think that this is an abstract that deserved the press that it received. Dr. Sweetenham: Yeah, absolutely, and it is going to be very interesting, I think, over the next 2 or 3 years to see how much impact this particular study might have on programs across the country and across the world actually, in terms of what they do in this kind of adjuvant setting for structured exercise. Dr. Hamilton: Absolutely.  So let's move on to Abstract 3006. This was an NCI-led effort comparing genomic testing using ctDNA and tissue from patients with less common cancers who were enrolled in but not eligible for a treatment arm of the NCI-MATCH trial. Tell us about your takeaways from this study. Dr. Sweetenham: Yeah, so I thought this was a really interesting study based, as you said, on NCI-MATCH. And many of the listeners will probably remember that the original NCI-MATCH study screened almost 6,000 patients to assess eligibility for those who had an actionable mutation. And it turned out that about 60% of the patients who went on to the study had less common tumors, which were defined as anything other than colon, rectum, breast, non–small cell lung cancer, or prostate cancer. And most of those patients lacked an eligible mutation of interest and so didn't get onto a trial therapy. But with a great deal of foresight, the study group had actually collected plasma samples from these patients so that they would have the opportunity to look at circulating tumor DNA profiles with the potential being that this might be another way for testing for clinically relevant mutations in some of these less common cancer types. So initially, they tested more than 2,000 patients, and to make a somewhat complicated story short, there was a subset of five histologies with a larger representation in terms of sample size. And these were cholangiocarcinoma, small cell lung cancer, esophageal cancer, pancreatic, and salivary gland cancer. And in those particular tumors, when they compared the ctDNA sequencing with the original tumor, there was a concordance there of around 84%, 85%. And in the presentation, the investigators go on to list the specific mutated genes that were identified in each of those tumors. But I think that the other compelling part of this study from my perspective was not just that concordance, which suggests that there's an opportunity there for the use of ctDNA instead of tumor biopsies in some of these situations, but what was also interesting was the fact that there were several clinically relevant mutations which were detected only in the circulating tumor DNA. And a couple of examples of those included IDH1 for cholangiocarcinoma, BRAF and p53 in several histologies, and microsatellite instability was most prevalent in small cell lung cancer in the ctDNA. So I think that what this demonstrates is that liquid biopsy is certainly a viable screening option for patients who are being assessed for matching for targeted therapies in clinical trials. The fact that some of these mutations were only seen in the ctDNA and not in the primary tumor specimen certainly suggests that there's some tumor heterogeneity. But I think that for me, the most compelling part of this study was the fact that many of these mutations were only picked up in the plasma. And so, as the authors concluded, they believe that a comprehensive gene profiling with circulating tumor DNA probably should be included as a primary screening modality in future trials of targeted therapy of this type. Dr. Hamilton: Yeah, I think that that's really interesting and mirrors a lot of data that we've been seeing. At least in breast cancer, you know, we still do a biopsy up front to make sure that our markers, we're still treating the right disease that we think we are. But it really speaks to the utility of using ctDNA for serial monitoring and the emergence of mutations. Dr. Sweetenham: Absolutely. And you mentioned breast cancer, and so I'd like to dwell on that for a moment here because obviously, there was a huge amount of exciting breast cancer data presented at the meeting this year. And in particular, I'd like to ask you about LBA1008, the DESTINY-Breast09 clinical trial, which I think has the potential to establish a new first-line standard of care for metastatic HER2+ breast cancer. And that's an area where we haven't seen a whole lot of innovation for around a decade now. So can you give us some of the highlights of this trial and what your thinking is, having seen the results? Dr. Hamilton: Yeah, absolutely. So this was a trial in the first-line metastatic HER2 setting. So this was looking at trastuzumab deruxtecan. We certainly have had no shortage of reports around this drug, initially approved for later lines. DESTINY-Breast03 brought it into our second-line setting for HER2+ disease and we're now looking at DESTINY-Breast09 in first-line. So this actually was a 3-arm trial where patients were randomized 1:1:1 against standard taxane/trastuzumab/pertuzumab in one arm; trastuzumab deruxtecan with pertuzumab in another arm; and then a third arm, trastuzumab deruxtecan alone. And what we did not see reported was that trastuzumab deruxtecan-alone arm. But we did have reports from the trastuzumab deruxtecan plus pertuzumab versus the chemo/trastuzumab/pertuzumab. And what we saw was a statistically significant improvement in median progression-free survival, 26.9 months up to 40.7, so an improvement of 13.8 months, over a year in PFS. Not to mention that we're now in the 40-month range for PFS in first-line disease. Really, across all subgroups, we really weren't able to pick out a subset of patients that did not benefit. We did see about a 12% ILD rate with trastuzumab deruxtecan. That really is on par with what we've seen in other studies, around 10%-15%. I think that this is going to become a new standard of care in the first-line. I think it did leave some unanswered questions. We saw some data from the PATINA trial this past San Antonio Breast, looking at the addition of endocrine therapy with or without a CDK4/6 inhibitor, palbociclib, for those patients that also have ER+ disease, after taxane has dropped out in the first-line setting. So how we're going to kind of merge all this together is, I suspect that there are going to be patients that we or they just don't have the appetite to continue 3 to 4 years of trastuzumab deruxtecan. And so we're probably going to be looking at a maintenance-type strategy for them, maybe integrating the PATINA data there. But how we really put this into practice in the first-line setting and if or when we think about de-escalating down from trastuzumab deruxtecan to antibody therapy are some lingering questions. Dr. Sweetenham: Okay, so certainly is going to influence practice, but watch this space for a little bit longer, it sounds as though that's what you're saying. Dr. Hamilton: Absolutely.  So let's move on to GI cancer. Abstract 4006 reported preliminary results from the randomized phase 2 study of elraglusib in combination with gemcitabine/nab-paclitaxel versus the chemo gemcitabine/nab-paclitaxel alone in patients with previously untreated metastatic pancreatic cancer. Can you tell us more about this study? Dr. Sweetenham: Yeah, absolutely. As you mentioned, elraglusib is actually a first-in-class inhibitor of GSK3-beta, which has multiple potential actions in pancreatic cancer. But the drug itself may be involved in mediating drug resistance as well as in some tumor immune response modulation. Some of that's not clearly understood, I believe, right now. But certainly, preclinical data suggests that the drug may be effective in preclinical models and may also be effective in combination with chemotherapy and potentially with immune-modulating agents as well. So this particular study, as you said, was an open-label, randomized phase 2 study in which patients with pancreatic cancer were randomized 2:1 in favor of the elraglusib plus GMP—gemcitabine and nab-paclitaxel—versus the chemotherapy alone. And upon completion of the study, which is not right now, median overall survival was the primary end point, but there are a number of other end points which I'll talk about in just a moment. But the sample size was planned to be around 207 patients. The primary analysis included 155 patients in the combination arm versus 78 patients in the gemcitabine/nab-paclitaxel arm. Overall, the 1-year overall survival rate was 44.1% for the patients in the elraglusib-containing arm versus 23.0% in the patients receiving gemcitabine/nab-paclitaxel only. When they look at the median overall survival, it was 9.3 months for the experimental arm versus 7.2 months for chemotherapy alone. So put another way, there's around a 37% reduction in the risk of death with the use of this combination arm. The treatment was overall well-tolerated. There were some issues with grade 1 to 2 transient visual impairment in a large proportion of the patients. The most common treatment-related adverse effects with the elraglusib/GMP combination was transient visual impairment, which affected around 60% of the patients. Most of the more serious treatment-related adverse events included neutropenia, anemia, and fatigue in 50%, 25%, and 16% of the patients, respectively. So the early results from this study show a significant benefit for 1-year overall survival and for median overall survival with, as I mentioned above, a significant reduction in the risk of death. The authors went on to mention that the median overall survival for the control arm in this study is somewhat lower than in other comparable trials, but they think that this may be related to a more advanced disease burden in this particular study. Of interest to me was that right now: there is no apparent difference in progression-free survival between the 2 arms of this study. The authors described this as potentially indicating that this may be related in some way to immune modulation and immune effects on the tumor, which, if I'm completely honest, I don't totally understand. And so, the improvement in overall survival, as far as I can see at the moment, is not matched by an improvement in progression-free survival. So I think we probably need to wait for more time to elapse to see what happens with the study. And so, I think it certainly is an interesting study, and the results are intriguing, but I think it's probably a little early for it to actually shift the treatment paradigm in this disease. Dr. Hamilton: Fantastic. I think we've been waiting for advances in pancreatic cancer for a long time, but this, not unlike others, we learn more and then learn more we don't realize, so. Dr. Sweetenham: Right. Let's shift gears at this point and talk about a couple of other abstracts in kind of a very different space. Let's start out with symptom management for older adults with cancer. We know that undertreated symptoms are common among the older patient population, and Abstract 11002 reported on a randomized trial that demonstrated the effects of remote monitoring for older patients with cancer in terms of kind of symptoms and so on. Can you tell us a little bit about this study and whether you think this approach will potentially improve care for older patients? Dr. Hamilton: Yeah, I really liked this abstract. It was conducted through the Veterans Affairs, and it was based in California, which I'm telling you that because it's going to have a little bit of an implication later on. But essentially, adults that were 75 years or older who were Medicare Advantage beneficiaries were eligible to participate. Forty-three clinics in Southern California and Arizona, and patients were randomized either into a control group of usual clinic care alone, or an intervention group, which was usual care plus a lay health worker-led proactive telephone-based weekly symptom assessment, and this was for 12 months using the validated Edmonton Symptom Assessment System. So, there was a planned enrollment of at least 200 patients in each group. They successfully met that. And this lay health worker reviewed assessments with a physician assistant, who conducted follow-up for symptoms that changed by 2 points from a prior assessment or were rated 4 or greater. So almost a triage system to figure out who needed to be reached out to and to kind of work on symptoms. What I thought was fantastic about this was it was very representative of where it enrolled. There were actually about 50% of patients enrolled here that were Hispanic or Latinos. So some of our underserved populations and really across a wide variety of tumor types. They found that the intervention group had 53% lower odds of emergency room use, 68% lower odds of hospital use than the control group. And when they translated this to actual total cost of care, this was a savings of about $12,000 U.S. per participant and 75% lower odds of a death in an acute care facility. So I thought this was really interesting for a variety of reasons. One, certainly health care utilization and cost, but even more so, I think any of our patients would want to prevent hospitalizations and ER visits. Normally, that's not a fantastic experience having to feel poorly enough that you're in the emergency room or the hospital. And really showing in kind of concrete metrics that we were able to decrease this with this intervention. In terms of sustainability and scalability, I think the question is really the workforce to do this. Obviously, you know, this is going to take dedicated employees to have the ability to reach out to these patients, etc., but I think in value-based care, there's definitely a possibility of having reimbursement and having the funds to institute a program like this. So, definitely thought-provoking, and I hope it leads to more interventions. Dr. Sweetenham: Yeah, we've seen, over several years now, many of these studies which have looked at remote symptom monitoring and so on in this patient population, and many of them do show benefits for that in kinds of end points, not the least in this study being hospitalization and emergency room avoidance. But I think the scalability and personnel issue is a huge one, and I do wonder at some level whether we may see some AI-based platforms coming along that could actually help with this and provide interactions with these patients outside of actual real people, or at least in combination with real people. Dr. Hamilton: Yeah, that's a fantastic point.  So let's talk a little bit about clinical trials. So eligibility assessment for oncology clinical trials, or prescreening, really relies on manual review of unstructured clinical notes. It's time-consuming, it's prone to errors, and Abstract 1508 reported on the final analysis of a randomized trial that looked at the effect of human-AI teams prescreening for clinical trial eligibility versus human-only or AI-only prescreening. So give us more good news about AI. What did the study find? Dr. Sweetenham: Yeah, this is a really, a really interesting study. And of course, any of us who have ever been involved in clinical trials will know that accrual is always a problem. And I think most centers have attempted, and some quite successfully managed to develop prescreening programs so that patients are screened by a health care provider or health care worker prior to being seen in the clinic, and the clinical investigator will then already know whether they're going to be eligible for a trial or not. But as you've already said, it's a slow process. It's typically somewhat inefficient and requires a lot of time on the part of the health care workers to actually do this in a successful way. And so, this was a study from Emory University where they took three models of ways in which they could assess the accuracy of the prescreening of charts for patients who are going to be considered for clinical trials. One of these was essentially the regular way of having two research coordinators physically abstract the charts. The second one was an AI platform which would extract longitudinal EHR data. And then the third one was a combination of the two. So the AI would be augmented by the research coordinator or the other way around. As a gold standard, they had three independent oncology reviewers who went through all of these charts to provide what they regarded as being the benchmark for accuracy. In a way, it's not a surprise to me because I think that a number of other systems which have used this combination of human verification of AI-based tools, it actually ultimately concluded that the combination of the two in terms of chart accuracy was for the most part better than either one individually, either the research coordinator or the AI alone. So I'll give you just a few examples of where specifically that mattered. The human plus AI platform was more accurate in terms of tumor staging, in terms of identifying biomarker testing and biomarker results, as well as biomarker interpretation, and was also superior in terms of listing medications. There are one or two other areas where either the AI alone was somewhat more accurate, but the significant differences were very much in favor of a combination of human + AI screening of these patient charts. So, in full disclosure, this didn't save time, but what the authors reported was that there were definite efficiency gains, and presumably this would actually become even more improved once the research coordinators were somewhat more comfortable and at home with the AI tool. So, I thought it was an interesting way of trying to enhance clinical trial accrual up front by this combination of humans and technology, and I think it's going to be interesting to see if this gets adopted at other centers in the future. Dr. Hamilton: Yeah, I think it's really fascinating, all the different places that we can be using AI, and I love the takeaway that AI and humans together are better than either individually. Dr. Sweetenham: Absolutely.  Thanks once again, Dr. Hamilton, for sharing your insights with us today and for all of the incredible work you did to build a robust program. And also, congratulations on what was, I think, a really remarkable ASCO this year, one of the most exciting for some time, I think. So thank you again for that. Dr. Hamilton: Thanks so much. It was really a pleasure to work on ASCO 2025 this year. Dr. Sweetenham: And thank you to our listeners for joining us today. You'll find links to all the abstracts we discussed today in the transcript of this episode. Be sure to catch up on all of our coverage from the Annual Meeting. You can catch up on my daily reports that were published each day of the Annual Meeting, featuring the key science and innovations presented. And we'll have wrap-up episodes publishing in June, covering the full spectrum of malignancies from ASCO25. If you value the insights you hear on the ASCO Daily News Podcast, please remember to rate, review, and subscribe wherever you get your podcasts. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.   More on today's speakers: Dr. John Sweetenham   Dr. Erika Hamilton @erikahamilton9   Follow ASCO on social media:  @ASCO on Twitter  ASCO on Bluesky  ASCO on Facebook   ASCO on LinkedIn     Disclosures:     Dr. John Sweetenham:     No relationships to disclose    Dr. Erika Hamilton: Consulting or Advisory Role (Inst): Pfizer, Genentech/Roche, Lilly, Daiichi Sankyo, Mersana, AstraZeneca, Novartis, Ellipses Pharma, Olema Pharmaceuticals, Stemline Therapeutics, Tubulis, Verascity Science, Theratechnologies, Accutar Biotechnology, Entos, Fosun Pharma, Gilead Sciences, Jazz Pharmaceuticals, Medical Pharma Services, Hosun Pharma, Zentalis Pharmaceuticals, Jefferies, Tempus Labs, Arvinas, Circle Pharma, Janssen, Johnson and Johnson   Research Funding (Inst): AstraZeneca, Hutchison MediPharma, OncoMed, MedImmune, Stem CentRx, Genentech/Roche, Curis, Verastem, Zymeworks, Syndax, Lycera, Rgenix, Novartis, Millenium, TapImmune, Inc., Lilly, Pfizer, Lilly, Pfizer, Tesaro, Boehringer Ingelheim, H3 Biomedicine, Radius Health, Acerta Pharma, Macrogenics, Abbvie, Immunomedics, Fujifilm, eFFECTOR Therapeutics, Merus, Nucana, Regeneron, Leap Therapeutics, Taiho Pharmaceuticals, EMD Serono, Daiichi Sankyo, ArQule, Syros Pharmaceuticals, Clovis Oncology, CytomX Therapeutics, InventisBio, Deciphera, Sermonix Pharmaceuticals, Zenith Epigentics, Arvinas, Harpoon, Black Diamond, Orinove, Molecular Templates, Seattle Genetics, Compugen, GI Therapeutics, Karyopharm Therapeutics, Dana-Farber Cancer Hospital, Shattuck Labs, PharmaMar, Olema Pharmaceuticals, Immunogen, Plexxikon, Amgen, Akesobio Australia, ADC Therapeutics, AtlasMedx, Aravive, Ellipses Pharma, Incyte, MabSpace Biosciences, ORIC Pharmaceuticals, Pieris Pharmaceuticals, Pieris Pharmaceuticals, Pionyr, Repetoire Immune Medicines, Treadwell Therapeutics, Accutar Biotech, Artios, Bliss Biopharmaceutical, Cascadian Therapeutics, Dantari, Duality Biologics, Elucida Oncology, Infinity Pharmaceuticals, Relay Therapeutics, Tolmar, Torque, BeiGene, Context Therapeutics, K-Group Beta, Kind Pharmaceuticals, Loxo Oncology, Oncothyreon, Orum Therapeutics, Prelude Therapeutics, Profound Bio, Cullinan Oncology, Bristol-Myers Squib, Eisai, Fochon Pharmaceuticals, Gilead Sciences, Inspirna, Myriad Genetics, Silverback Therapeutics, Stemline Therapeutics

There are many acronyms, terms, and procedures patients hear either in consultation with their plastic surgeon or online through various social media groups and platforms. Our guest on this edition of the DiepCJourney podcast is a board-certified microsurgeon who will help us sort out three of those terms today. The delay procedure, SIEA, and TDAP in breast reconstruction surgery. We appreciate everyone who is utilizing the DiepCFoundation resources. Be sure to click here for the video interview with my guest at the DiepCFoundation YouTube channel. I am joined by Dr. James Craigie, who specializes and is trained in microsurgery. The primary focus at his practice at The Center for Natural Breast Reconstruction in Mt. Pleasant, SC, is performing complex breast reconstruction procedures which we will discuss in this interview. I want to highlight that Dr. Craigie works with a team of microsurgeons practicing the co-surgeon model in breast reconstruction surgery. To learn more about the benefits of the co-surgeon model check out a previous episode of the DiepCJourney podcast by clicking here. At the Foundation, our focus is to provide accurate information to our listeners and why I ask Dr. Craigie to join us to discuss specific procedures in this interview. The paper I reference in the interview on the value of the co-surgeon model in breast reconstruction can be found and read by clicking here. Connect with Dr. Craigie and his practice on the following platforms. Instagram: https://www.instagram.com/natural.breast.reconstruction/ Facebook: https://www.facebook.com/naturalbreastreconstruction LinkedIn: The Center for Natural Breast Reconstruction

TODAY ON THE ROBERT SCOTT BELL SHOW: RFK Defends Science, MAHA FDA Roadblock, Breast Cancer Rising, Endocrine Disruptors Impair Fertility, Ozempic as Cancer Cure?, Glycerinum, Following Orders vs Moral Compass, Arsenic Low Birthweight, Microbiome Clinical Care, Microplastic Brain, Mariachi's Replaced and MORE! https://robertscottbell.com/rfk-defends-science-maha-fda-roadblock-breast-cancer-rising-endocrine-disruptors-impair-fertility-ozempic-as-cancer-cure-glycerinum-following-orders-vs-moral-compass-arsenic-low-birthweight-m/ Please read this disclaimer carefully before you (“you”, “your”) use our [Your Website URL] website (“website”, “service”) operated by the [Your Business Name] (“operator”, “us”, “we”, “our”). Purpose and Character The use of copyrighted material on the website is for non-commercial, educational purposes, and is intended to provide benefit to the public through information, critique, teaching, scholarship, or research. Nature of Copyrighted Material Weensure that the copyrighted material used is for supplementary and illustrative purposes and that it contributes significantly to the user's understanding of the content in a non-detrimental way to the commercial value of the original content. Amount and Substantiality Our website uses only the necessary amount of copyrighted material to achieve the intended purpose and does not substitute for the original market of the copyrighted works. Effect on Market Value The use of copyrighted material on our website does not in any way diminish or affect the market value of the original work. We believe that our use constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the U.S. Copyright Law. If you believe that any content on the website violates your copyright, please contact us providing the necessary information, and we will take appropriate action to address your concern.

Host Melissa Berry sits down with Melissa Eppard, a triple negative breast cancer survivor and co-founder of Upstate Mary, a wellness brand focused on CBD-infused intimacy products. They talk about Melissa's personal breast cancer experience and the challenges many patients face with intimacy during and after treatment. Their conversation highlights the importance of addressing issues like vaginal dryness and the need for lubrication, which are often misunderstood, overlooked, and surrounded by shame. Melissa shares how CBD can help improve comfort and sexual wellness, while normalizing these conversations and taking the shame away. They also discuss the pressures both cancer survivors as well as their partners can feel around intimacy and the power of community support in reclaiming confidence and connection after cancer. This episode offers honest insights and encourages open conversations about sexual health for cancer survivors and their partners.

Has cancer ever made you feel like you're losing a piece of yourself, especially your identity? Imagine facing hair loss from treatment, only to find the wig options available don't reflect who you are. This isn't just about hair; it's about dignity, self-esteem, and seeing yourself truly represented.In this powerful rebroadcast, join your host, Talaya Dendy, on Navigating Cancer TOGETHER as she welcomes the incredible Dianne Austin. A breast cancer survivor herself, Dianne co-founded Coils to Locs, a groundbreaking initiative born out of a deeply personal struggle. Prepare to be inspired by her journey to transform the wig industry and support women of color facing hair loss due to cancer and other medical conditions.

Camidge and O'Riordan discussed how O'Riordan's breast surgery career intersected with her personal experience with breast cancer. She shared the stories behind her initial diagnosis, subsequent treatments, and disease recurrences. She also emphasized the importance of open communication with patients about aspects of cancer survivorship, such as emotional wellbeing and sexual health. O'Riordan also talked about her career transition from the surgery field to patient advocacy, as well as her future plans for writing, speaking, and offering support to the breast cancer community. 

In this episode of the ACRO podcast CURiE edition, CURiE Channel Editor Dr. Jessica Schuster speaks with author Dr. Shearwood McClelland, III about his published article, "Early Implementation of the Navigator-Assisted Hypofractionation (NAVAH) Program in Hispanic-American Breast Cancer Patients." Contemporary Updates: Radiotherapy Innovation & Evidence (CURiE) is the official publication platform of the American College of Radiation Oncology through the Cureus Journal of Medical Science.Read the article here: https://www.cureus.com/articles/363179-early-implementation-of-the-navigator-assisted-hypofractionation-navah-program-in-hispanic-american-breast-cancer-patients#!/

When a loved one is diagnosed with breast cancer, the journey touches every corner of life —especially for caregivers. In honor of Black Family Cancer Awareness Week, for this powerful episode of Real Pink, we sit down with two incredible Black men of faith, Kenneth White, spiritual adviser and group facilitator for a national addiction treatment center, and John K. Conner of Praise Is the Cure, a nonprofit focused on breast cancer awareness in the Black community, as they open up about supporting their wives through breast cancer. Through a lens of faith and cultural identity, Kenneth and John reflect on what it means to show up with strength and vulnerability, how spirituality grounds their caregiving and the importance of community for Black families facing a diagnosis. Their stories illuminate a side of breast cancer that's often unheard — but deeply needed.

Red Lights, Green Lights – Understanding Breast Cancer RiskIn today's episode, Dr. Barbara 'Menopause' Taylor uses a simple analogy to explain the progression and prevention of breast cancer. She explores how various genetic, hormonal, and lifestyle factors act as either red lights (stopping cancer) or green lights (allowing it to develop). With clarity and compassion, she empowers you to become your own “traffic cop” in managing risk and making informed decisions about your health during menopause.Visual learner? Find the corresponding Menopause Taylor YouTube video here. Click here for more about one-on-one consultations and Dr. Taylor's menopause resources. Looking for a roadmap to successful menopause management? Dr. Taylor's new ebook, How to Win at Menopause: A Guide to Raising - and Winning- Your Game Your Way, will bring confidence and clarity to your menopause journey. Avoid common pitfalls and learn to navigate a healthcare system that focuses more on disease than prevention, where many professionals lack the relevant education and/or the motivation to help you.

Welcome to another powerful episode of The Power of Owning Your Career podcast! Have you ever wondered what it truly takes to pivot from a successful corporate path to building your own empire, all while navigating life's biggest challenges? This week, host Simone E. Morris interviews the phenomenal Dr. Cree Scott—founder and CEO of Serenity Psy Consulting, an executive coach, and a consulting psychologist with over 15 years of experience. Dr. Scott brings a wealth of knowledge in human-centered leadership development, change management, and cultivating employee well-being.   Dr. Scott shares her remarkable and often winding journey to entrepreneurship in this incredibly inspiring conversation. You'll hear about the pivotal moments that led her to bravely leave a thriving corporate role, how her courageous battle with breast cancer profoundly reshaped her approach to career ownership and well-being, and the wisdom she gained every step of the way.   Simone and Dr. Scott dive deep into critical strategies for aligning your professional life with your deepest personal values, the essential role of experimentation and faith when taking bold career risks, and the immense power of staying curious and connected throughout your professional evolution. Dr. Scott also opens up about the invaluable lessons gleaned from her diverse experiences—from thriving as a consultant at major firms to her lifelong pursuit of learning and growth.   Whether you're actively contemplating a significant career pivot, searching for tangible ways to take charge of your professional path, or simply looking for the ultimate inspiration to bet on yourself, this episode is an absolute must-listen. It's packed with practical insights, heartfelt stories, and the motivation you need to confidently get—and stay—in the driver's seat of your own career.   Don't miss a single moment of this transformative conversation! Tune in now and start owning your career today.   Episode Time Stamp: 00:00 Career Reflection: Lost in Advancement 03:43 Reevaluating Life and Career Choices 07:15 Finding Spirituality After Cancer 12:57 "Charting My Leadership Path" 14:35 "Embracing Adventure with Purpose" 17:37 Impact of Doctorate Degree 20:55 Betting on Faith and Self 24:06 Embracing Life's Uncertainty 27:00 "Connector of Diverse Identities"   ✴️ Resources: Book Recommendations: Reinventing You by Dorie Clark The Untethered Soul by Michael Singer The Seat of the Soul by Gary Zukav Books by Wayne Dyer Audible (as a resource for listening to books) Virtual connections and networking conversations Serenity Psy Health website (www.serenity.psyhealth.com) LinkedIn for professional networking   ✴️ Connect with our guest, Dr. Cree Scott: Dr. Cree Scott recommends reaching out to her on LinkedIn—search for "Cree Scott" (with or without the "Dr." in front). She personally manages her social media and welcomes direct messages if you want to connect or have a conversation. You can also visit her website at www.serenity.psyhealth.com for more information.   ✴️ Connect with the show's host, Simone E. Morris: https://www.linkedin.com/in/simonemorris/   ✴️ Want to apply to be a guest or recommend someone for the show?   Visit: https://bit.ly/pooycshowguest   ✴️ Get More Support for Your Career:

Featuring perspectives from Dr Virginia F Borges, Ms Jamie Carroll, Mr Ronald Stein and Dr Seth Wander, including the following topics: Introduction (0:00) Role of CDK4/6 Inhibitors in Localized and Metastatic Hormone Receptor (HR)-Positive Breast Cancer (12:49) PI3K Inhibition as First-Line Treatment for HR-Positive, HER2-Negative Metastatic Breast Cancer (mBC) (38:24) Clinical Utility of AKT and PI3K Inhibitors in Progressive HR-Positive mBC (1:01:44) Current and Future Role of Oral Selective Estrogen Receptor Degraders in HR-Positive mBC (1:24:38) NCPD information and select publications

Is weight gain one of your post-treatment challenges? While treatment can be both a direct and indirect cause of weight gain, your weight may be up for reasons you've not even considered! Tune in to this episode to find out what they are as I highlight and explain hidden reasons behind your tighter jeans and a higher number on the scale._____________________________________Click here to apply to my Peaceful Plate program! Get my FREE guide The Five Foods Survivors Should Eat; click here!Follow me on Instagram @hormone.breastcancer.dietitian

In this episode, we unpack game-changing insights from ASCO 2025 with a spotlight on breast cancer. Joining us is Dr. Adam Brufsky, a trailblazing oncologist and professor at the University of Pittsburgh, with 30 years of experience, whose expertise has helped shape the direction of treatment. Trials discussed include the SERENA-6 trial, which examines camizestrant plus CDK4/6 inhibitors in HR-positive, ESR1 mutation breast cancer; the DESTINY-Breast09 trial, highlighting trastuzumab deruxtecan in combination with pertuzumab; and the INAVO120 trial, revealing inavolisib's triplet therapy response in PIK3CA-mutated, HR-positive, HER2-negative disease. Join us for a deep dive into these game-changing findings and their impact on patient care.Studies discussed in the episode:SERENA-6DESTINY BREAST 09INAVO 120For more episodes, resources and blog posts, visit www.inquisitiveonc.comPlease find us on Twitter @InquisitiveOnc!If you want us to look at a specific trial or subject, email us at inquisitiveonc@gmail.comArt courtesy of Taryn SilverMusic courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.Oncology for the Inquisitive Mind is recorded with the support of education grants from our foundation partners Pfizer, Gilead Pharmaceuticals and Merck Pharmaceuticals. Our partners have access to the episode at the same time you do and have no editorial control over the content. Hosted on Acast. See acast.com/privacy for more information.

"In my mind, I'm not going anywhere anytime soon." It's been a whirlwind week. THANK YOU for all of the love, support, and kindness after last week's "we're due for a catch-up" episode. It's been an overwhelming time for me — but what about for my support squad? I get so many questions from people asking how best to show up for someone going through a hard time, and my team and I have learned a lot about what this can all look like. So for this one, Cousin Jackie returns, and we're talking about what the past few weeks have been like for each of us: the patient and the support person. SPONSORS:  Oofos: The best in recovery footwear! Check out Oofos's 2025 Project Pink collection, where 10% of every purchase is donated to cancer research.  Vuori: Click here for 20% off your first Vuori purchase. Follow Ali: Instagram @aliontherun1 Join the Facebook group Support on Patreon Subscribe to the newsletter SUPPORT the Ali on the Run Show! If you're enjoying the show, please subscribe and leave a rating and review on Apple Podcasts. Spread the run love. And if you liked this episode, share it with your friends!

In this episode of The Breast Cancer Recovery Coach, we'll dismantle three of the most common—and misleading—nutrition myths that many women encounter after a breast cancer diagnosis. Whether you're in active treatment or navigating life post-cancer, this conversation offers clarity, compassion, and practical advice rooted in science, not fear.   You'll learn: Why not all carbohydrates are harmful and how whole-food carbs can actually support healing The truth about plant vs. animal foods and how to identify clean, high-quality animal proteins How “organic” and “plant-based” labels can mislead your food choices—and what to look for instead If you've ever felt confused or overwhelmed by nutrition advice, this episode will help you reconnect with your body, make informed choices, and feel confident in the way you nourish yourself. Topics Covered: The real difference between simple and complex carbohydrates How to eat carbs while maintaining stable blood sugar Nutrient density and bioavailability of animal vs. plant foods What qualifies as a clean animal food and why it matters The “health halo effect” of organic and plant-based labels Tips for tuning out food fear and tuning into what works for your body   Resources & References: Work with Laura Study: Glycemic load and cancer risk – Nutrition Journal Study: Dietary fiber intake and breast cancer – Annals of Oncology Study: Macronutrient combinations and glycemic response – Diabetes Care Study: Organic labeling and perception – Food Quality and Preference Study: Health halo of plant-based labels – Appetite (2018) Study: Plant-based health halo and risk perception – Appetite (2019)   Loved this episode? Share it with a friend or leave a review on Apple Podcasts to help more survivors find compassionate, clear guidance on living well after breast cancer.   Connect with Laura Lummer:

 NEW EPISODE | The Doctor Who Couldn't Zip Her Dress: A Breast Cancer StoryThis week on The Brain Love Podcast, Dr. Delvena Thomas sits down with a courageous family practice physician, Dr. Michelle Powell, who became the patient.  Diagnosed with breast cancer during the pandemic, she opens up about the emotional rollercoaster of treatment—from the strength it took to keep practicing medicine, to the day chemo made her too weak to zip her own dress.As a psychiatrist, Dr. Thomas was deeply moved by her vulnerability, her resilience, and the raw honesty she brings to this conversation. This isn't just a story about survival—it's a story about identity, womanhood, and healing. “I couldn't even zip my dress… and I'm a doctor. I help people heal—but I couldn't help myself.” Tune in for a powerful blend of medical insight and human connection. We are in season 6, epi #2!#BrainLovePodcast #BreastCancerAwareness #SurvivorStory #PhysiciansArePatientsToo #MentalHealthMatters #HealingJourney #WomenInMedicine #Resilience #ChemoChronicles #BlackDoctorsMatter #UnzipTheStigma#BrainLove

Heartfelt tributes pour in for former MTV and BET host Ananda Lewis, who passed away at 52 after a seven-year battle with breast cancer. Known for her authenticity, advocacy, and shining presence on Teen Summit and Total Request Live, Ananda used her platform to encourage early cancer screening and embrace tough health conversations. See omnystudio.com/listener for privacy information.

In this week’s The Rickey Smiley Morning Show Podcast, heartfelt tributes pour in for former MTV and BET host Ananda Lewis, who passed away at 52 after a seven-year battle with breast cancer. Known for her authenticity, advocacy, and shining presence on Teen Summit and Total Request Live, Ananda used her platform to encourage early cancer screening and embrace tough health conversations. The show also covers Simon Guobadia’s deportation back to Nigeria by ICE—a move that complicates his divorce from RHOA star Porsha Williams and stirred debate about immigration enforcement and celebrity courts. Tyrese Gibson joins the crew in studio to promote his involvement on the Tom Joyner cruise and share his unfiltered thoughts on staying relevant and releasing new music. Finally, Nicki Minaj drops her latest hot-take alongside Lil Wayne in the “Banned from NO” remix—laying into the NFL for overlooking Lil Wayne during the Super Bowl halftime, reigniting conversations around hip-hop’s role in sports entertainment. Website: https://www.urban1podcasts.com/rickey-smiley-morning-show See omnystudio.com/listener for privacy information.

Today's guest is discussing genetic testing, specifically because she has tested positive for a strong breast cancer gene. She believes this is the same gene that caused her mother to have breast cancer. I've often wondered, if a close relative has had cancer, does that increase my chances of developing it as well? What steps can be taken to prevent cancer if there is a significant family history of it? How "close" does a relative need to be for their cancer diagnosis to raise their own risk? Krista answered all these questions and so many more. This is a tricky topic, and I'll be honest, it's a little scary when you think about getting tested to see if you have a higher likelihood of cancer. However, Krista is very clear that knowledge is power, and it's better to understand the risks associated with your genetics so you can take action to mitigate them. A couple of our takeaways: We had an enlightening conversation about the relationship between stress and cancer. We both know that stress plays a huge role in cancer. We both agree that organic produce is the best choice, though we recognize that it can be expensive. We discussed some creative strategies for incorporating 8 to 10 servings of organic produce into our daily diets without overspending. ______ Bon Charge Do you want to know one of my wellness secrets?  I'm a huge fan of red light therapy—it's been a powerful tool throughout my health journey. I've personally experienced its benefits in reducing inflammation, speeding up wound healing, and supporting muscle recovery.  Click here to see my favorite brand. ______ Just Add Buoy What to see what I'm drinking?! I've been looking for an electrolyte product for YEARS. This is why I'm so happy to have found BUOY Electrolyte drops. Click here to get 20% off my drink of the summer! ______ Connect with Krista Instagram: https://www.instagram.com/cancer.prevention.coach/?hl=en ______ Connect with Deborah Deborah on Instagram: https://www.instagram.com/whydidigetcancer/ Deborah on Facebook: https://www.facebook.com/DebsHealthCoachKitchen Deborah on Twitter: https://twitter.com/ydidigetcancer Deborah on Pinterest: https://in.pinterest.com/whydidigetcancer/ Join Deb's weekly newsletter!  -https://whydidigetcancer.us14.list-manage.com/subscribe?u=1c37affeccf004c8957941069&id=a8572db3c2

Please note: This episode has been updated to reflect a minor edit made after the initial relase.   On this episode of the Natasha Helfer Podcast, one of Natasha's providers, Sara Rands, ACMHC, joins to discuss her journey with a chronic illness and how that affects intimacy. She's Master Certified in Accelerated Resolution Therapy (ART), a brain-based therapy that clears stuck emotional patterns without the need to relive painful stories. Her approach blends structure and soul: existential therapy, mindfulness, ketamine-assisted psychotherapy (KAP), and current training in the NARM model for complex trauma. Sara works especially well with gifted, neurodiverse, and highly sensitive clients—analytical minds, deep thinkers, and those who've always moved through life a little differently. She brings lived wisdom from cancer survivorship, spiritual transitions, and parenting spectrum kids. With a background in both computer science and English, she offers a calm, curious, and focused presence and a rare ability to hold emotional complexity without simplifying it. Go here for more on Sara: https://symcounseling.com/sara-rands/   To help keep this podcast going, please consider donating at natashahelfer.com and share this episode. To watch the video of this podcast, you can subscribe to Natasha's channel on Youtube and follow her professional Facebook page at natashahelfer LCMFT, CST-S. You can find all her cool resources at natashahelfer.com.  The information shared on this program is informational and should not be considered therapy. This podcast addresses many topics around mental health and sexuality and may not be suitable for minors. Some topics may elicit a trigger or emotional response so please care for yourself accordingly. The views, thoughts and opinions expressed by our guests are their own and do not necessarily reflect the views or feelings of Natasha Helfer or the Natasha Helfer Podcast. We provide a platform for open and diverse discussions, and it is important to recognize that different perspectives may be shared. We encourage our listeners to engage in critical thinking and form their own opinions. The intro and outro music for these episodes is by Otter Creek. Thank you for listening. And remember: Symmetry is now offering Ketamine services. To find out more, go to symcounseling.com/ketamine-services. There are also several upcoming workshops. Visit natashahelfer.com or symcounseling.com to find out more.

In this episode I'm going to help you answer the question: should I be starting hormone replacement therapy during peri or post menopause? Over the past 23 years, there has been a lot of fear about hormone replacement therapy (HRT). The Women's Health Initiative originally reported a concern about breast cancer risk, and that led many women to avoid hormone replacement. A newly updated report from the same researchers has completely changed the perspective on hormone replacement. The researchers are now stating that HRT is not increasing breast cancer risk the way they once feared. Instead, HRT can actually decrease disease risk, including by decreasing heart disease, dementia, diabetes, and osteoporosis. That is such essential information, and such a shift in what we've been hearing, that I wanted to cover this topic in detail. Choosing hormone replacement therapy is a very individualized decision. It's important to understand and think through your medical history and your health risk factors. It's also important to work with a practitioner who understands the latest research. It is essential to individualize your doses and how hormones are delivered to your body (oral, cream, patch, etc). I'm going to cover how to find a practitioner who can guide you every step of the way. I'm here to help you! LINKS FROM THE EPISODE:   Take Dr. Doni's Stress Type Quiz: https://doctordoni.com/quiz/stress-quiz/   Menopause Program with Dr. Doni: https://dv296.infusionsoft.com/app/orderForms/Menopause    Sign up For Dr. Doni's Masterclasses: https://doctordoni.com/masterclasses/    Schedule A Chat With Dr. Doni: https://intakeq.com/new/hhsnib/vuaovx    Read the full episode notes and find more information: https://doctordoni.com/blog/podcasts/ MORE RESOURCES FROM DR. DONI:   Quick links to social media, free guides and programs, and more: https://doctordoni.com/links     Disclosure: Some of the links in this post are product links and affiliate links and if you go through them to make a purchase I will earn a commission at no cost to you. Keep in mind that I link these companies and their products because of their quality and not because of the commission I receive from your purchases. The decision is yours, and whether or not you decide to buy something is completely up to you.

Louise Foley (Flavin) joins me to share her journey through breast cancer, menopause, and rebuilding her health with a holistic low-tox lifestyle. You'll hear powerful insights on food, skincare, mental health and how to spot early signs from your gut, skin, and mood. One of the most inspiring conversations I've had yet.-Follow me on Instagram - https://www.instagram.com/colman_power_organic_fitness/ Join the CPOF Community for daily health, wellness and fitness advice - https://www.colmanpowerorganicfitness.com/cpofcommunitysignup 3 Secrets To Fix Your Energy (Free Guide) https://www.colmanpowerorganicfitness.com/organicstarterkit

In this episode, we continue with a special series close to my heart: Decoding Destiny: Navigating Breast Cancer with Genetic Insight. I'm joined by Kathy Baker, patient advocate and founder of My Faulty Gene to explore the power of genetic testing—particularly cascade testing—and how it can help both you and your family take control of your breast cancer risk. Kathy shares her compelling personal story and how it inspired her to launch My Faulty Gene, a nonprofit organization that provides education, emotional support, and financial assistance for genetic testing. You'll learn all about the importance of cascade testing for families, how genetic knowledge can lead to proactive screenings and preventive health measures, and how advocacy is truly paving the way for more accessible care. Whether you're facing a BRCA-positive diagnosis, considering genetic testing, or looking for support navigating hereditary cancer risk, this is one conversation that you'll want to listen to - and share with your entire family.  Thank you to Merck and AstraZeneca for making this episode possible!

In today's episode, we spoke with Paolo Tarantino, MD, about key updates in HER2-positive breast cancer presented at the 2025 ASCO Annual Meeting

What did you think of this episode?Finding the right endorsers for your book is possible!If you have endorsers, are they the right fit for your book? Today's encore episode shares six essential tips for finding and leveraging the best endorsements for your book. Welcome to Your Best Writing Life, an extension of the Blue Ridge Mountains Christian Writers Conference held in the beautiful Blue Ridge Mountains of North Carolina. I'm your host, Linda Goldfarb. Each week, I bring tips and strategies from experts in the writing and publishing industry to help you excel in your craft. I'm so glad you're listening in; during this highly praised encore episode, you'll learn the … Top Six Tips to Find and Use Book Endorsements.My industry expert is… Ginny Brant. Ginny is a speaker and writer who grew up in our nation's capital. Her award-winning book, Finding True Freedom, was endorsed by Chuck Colson. Her recent book, Unleash Your God-given Healing, has won five awards. Both books received media interviews nationwide. Ginny has also written over 200 articles. Ginny shares her Top Three Tips to Locate Endorsersand her Top Three Tips to Leverage Endorsements :Endorsers can be used to validate and market a book. Choose endorsers who bring different perspectives to your book's message. Be intentional in who you choose to write the forward. LINKSListener giveaway - Free tips for Reducing Risk for Breast Cancer  www.ginnybrant.com/unleashUnleash Your God-Given Healing: Eight Steps to Prevent and Survive Cancerhttps://www.amazon.com/Unleash-Your-God-Given-Healing-Prevent/dp/1973688123/      Finding True Freedom, From the White House to the World https://www.amazon.com/Finding-Freedom-White-House-World/dp/1936143097 You can find out more about Ginny Brant www.ginnybrant.com https://www.facebook.com/ginny.d.brant/  https://www.instagram.com/ginnydentbrant/     https://www.linkedin.com/in/ginny-brant-aa5153a/ Ginny Brant's Books:https://www.amazon.com/Unleash-Your-God-Given-Healing-Prevent/dp/1973688123/https://www.amazon.com/Finding-Freedom-White-House-World/dp/1936143097 Visit Your Best Writing Life website.Join our Facebook group, Your Best Writing LifeYour host - Linda Goldfarb#1 Podcast in the "Top 50+ Must-Have Tools and Resources for Christian Writers in 2024". Awarded the Spark Media 2022 Most Binge-Worthy PodcastAwarded the Spark Media 2023 Fan Favorites Best Solo Podcast

Ep 69: In this episode of Strength To Build, Chelsey sits down with actress, breast cancer survivor, and recent college grad - Miranda McKeon for an honest conversation about how her approach to health, fitness, and mental resilience helped her navigate breast cancer—diagnosed at just 19 years old.Miranda shares what her relationship with health looked like before her diagnosis, how she adapted her routine during treatment, and how she continues to rebuild both physically and emotionally after surviving cancer.This conversation is a reminder that fitness isn't just about aesthetics—it's a tool for strength, healing, and self-confidence. Miranda's story is vulnerable, powerful, and filled with insight for anyone navigating a health challenge or supporting someone who is.Follow Miranda on Instagram: @mirandamckeonStart your 7 day FREE trial of my new app HERE!Want to work one on one with Chelsey?Set up a one on one consultation call here to see if personalized online training is right for you.Join a semi-private class in LA here.Email info@chelseyrosehealth.com to inquire about one on one in person training.Follow Chelsey on Instagram:@Chelseyrosehealth@StrengthtobuildFollow Chelsey on TikTok Here."Submit a question to the show"

What do you do when cancer is always present in your family? David Mauk lost his mother, his sister, and other loved ones to breast cancer. He knows what it's like to grow up surrounded by the reality of cancer and to carry the BRCA gene. In today’s episode, you’ll hear: How genetic testing changed the choices his family made What it feels like to be a cancer advocate in Washington, D.C. Why sharing your family history can help save lives Support The Rose HERE. Subscribe to Let’s Talk About Your Breasts on Apple Podcasts, Spotify, iHeart, and wherever you get your podcasts. Key Questions Answered What impact did breast cancer have on David Mauk's family? What is the significance of the BRCA gene in David’s family? How did David’s family talk about breast cancer while he was growing up? How did David cope with losing his mother at such a young age? Did David himself undergo genetic testing and what were the results? How does David’s family approach genetic testing and health surveillance today? What has David done as an advocate for cancer research and awareness? Why does David believe early detection and knowing your family history is so crucial? What advice does David have for those with a family history of cancer? How has cancer research and treatment changed since previous generations? Timestamped Overview 00:00 Family, Cancer, Advocacy, Gene Awareness 04:31 Air Force Headsets Linked to Tumors 07:36 "Air Force Brat’s Journey" 11:07 Cancer Society Fundraising Champions 14:11 "Make Cancer Conversations Personal" 15:41 "Missing Maternal Memories" 22:00 Family Migration Journey 22:57 Living Positively Amidst Fear 25:57 Discovering Family Through DNA Insights 29:37 Empowering Young Women Against Breast CancerSee omnystudio.com/listener for privacy information.

In this powerful episode of Keeping Abreast, I sit down with renowned functional medicine pioneer Dr. Allen Magaziner to explore his transformative journey into integrative care. From the early days of facing resistance in a conventional medical landscape to building a thriving holistic practice, Dr. Magaziner shares how personal experiences—particularly his mother's health struggles—led him to challenge the status quo.Together, we unpack the many flaws in our current medical system, including the dangers of overdiagnosis, the overreliance on prescription medications, and the urgent need to prioritize health over disease management. This conversation dives deep into the misunderstood world of cholesterol, inflammation, and the often-overlooked role of nutritional deficiencies—especially vitamin D—in both cancer prevention and treatment.Listeners will be inspired by Dr. Magaziner's passion for integrative oncology, his insights into lifestyle medicine, and his message of hope for anyone facing cancer. The episode also honors the legacy of Suzanne Somers, who bravely championed hormone replacement therapy and encouraged women to reclaim their health after cancer. In This Episode, You Will Learn:-Dr. Magaziner's path into functional medicine began with his mother's illness-The limitations of conventional medicine spurred his shift toward integrative care-Overdiagnosis and prescription drug overuse are harming more than helping-Cholesterol is essential to health—context and nuance matter-Vitamin D regulates over 2,000 genes, including many with anti-cancer properties-Maintaining optimal vitamin D levels (>90 ng/mL) is critical in cancer care-Integrative oncology can radically improve both outcomes and quality of life-Repurposed medications, such as metformin, show promise in cancer therapy-Fear inhibits healing—support, mindset, and curiosity are vital-Suzanne Somers' legacy continues to empower women's wellness journeys 

WBBM's Carolina Garibay chats with a Chicago photographer about the Brave Pink Warrior Project, a series of photos of women who have survived breast cancer. She said the hope is to inspire women who are currently going through treatment.

WBBM's Carolina Garibay chats with a Chicago photographer about the Brave Pink Warrior Project, a series of photos of women who have survived breast cancer. She said the hope is to inspire women who are currently going through treatment.

Headlines: – Welcome to Mo News (02:00) – Trump Deploys National Guard To LA After Violence Anti-Ice Protests (05:40)– CA Governor Suing Administration Over Move (16:25)– Analysis On Why Trump Escalating Raids (17:40) – Abrego Garcia Is Back In The U.S. To Face Charges (24:15) – President Trump's Travel Ban Goes Into Effect Today (30:10) – Elon Musk's Behavior Behind Trump's Fallout With Ex-DOGE Head (33:10) – New Era in College Sports: Schools Cleared to Pay Student Athletes (37:40) – Younger Women See Alarming Rise in Breast Cancer Diagnoses (40:50) – French Open Champion's First Stop Revelation About Parents (44:00) – On This Day In History (47:20) Thanks To Our Sponsors: – LMNT - Free Sample Pack with any LMNT drink mix purchase – Industrious - Coworking office. 30% off day pass – Athletic Greens – AG1 Powder + 1 year of free Vitamin D & 5 free travel packs – Shopify – $1 per-month trial Code: monews – Incogni - 60% off an annual plan| Promo Code: MONEWS – Saily - 15% off any data plan | Promo Code: MONEWS

Need Prayer? Send Us a DM @chosenbyjesuscbj How do you anchor your faith when trauma tries to return-before you even know the outcome? In this powerful episode of Chosen by Jesus, Kelley Tyan and her daughter Taylor Tyan open up about discovering a new mass-more than a decade after surviving breast cancer. The fear came rushing back, but her response was different.  You'll learn how to: *Anchor your faith when anxiety resurfaces *Speak truth when emotions try to take over *Choose peace in the unknown *Trust God's presence more than your fear "We have this hope as an anchor for the soul, firm and secure." Hebrews 6:19 This one's for anyone walking through fear, illness, trauma, or spiritual storms. You're not alone. God is with you. CONNECT WITH KELLEY AND TAYLOR: Watch the show on YouTube ChosenbyJesus-CBJ Follow Kelley & Taylor on Instagram @chosenbyjesuscbj Visit Kelley's website: www.kelleytyan.com Grab Kelley's free 5 day devotional 

If your doctor is recommending that you get a mastectomy, you will likely have some choices about how the surgery is performed. Your breast cancer treatment, your body, your breast shape and your lifestyle affect not only your options, but also the pros and cons of your options. There's no one method that works best for everyone because each person is unique. Today we are going to be exploring one specific type of mastectomy – the nipple-sparing mastectomy. This is a skin-sparing mastectomy that leaves the nipple and areola intact and usually improves the overall look of the reconstructed breast. Joining us on the show today are two very special guests: Dr. Mara Piltin, a Breast and Melanoma Surgical Oncologist and Physician Assistant, Maddie Beiswanger, both from Mayo Clinic. They are going to tell us more about nipple-sparing mastectomy procedures, current research that is being conducted around the use of minimally invasive robotic surgery to assist in these procedures and the possible benefits that these innovations can provide. This episode of The Real Pink Podcast is brought to you by Intuitive Surgical. Intuitive is a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. Intuitive has been advancing minimally invasive care since 1995 with the goal of helping physicians improve the lives of people around the world. You can learn more at www.Intuitive.com

The Pathology of Breast Cancer (YouTube Video #386)In this episode, Dr. Barbara 'Menopause' Taylor demystifies the process of how normal breast cells become cancerous. Using clear analogies and a step-by-step breakdown, she walks you through the stages from healthy tissue to invasive cancer—showing how breast cancer develops slowly over time. Learn about different breast cancer types, the meaning behind terms like “hyperplasia” and “carcinoma in situ,” and why understanding pathology can bring you peace of mind.Visual learner? Find the corresponding Menopause Taylor YouTube video here. Click here for more about one-on-one consultations and Dr. Taylor's menopause resources. Looking for a roadmap to successful menopause management? Dr. Taylor's new ebook, How to Win at Menopause: A Guide to Raising - and Winning- Your Game Your Way, will bring confidence and clarity to your menopause journey. Avoid common pitfalls and learn to navigate a healthcare system that focuses more on disease than prevention, where many professionals lack the relevant education and/or the motivation to help you.

Carol Harvey's powerful journey from experienced nurse to breast cancer survivor offers a unique dual perspective that changes everything.Carol shares her unexpected triple-negative breast cancer diagnosis in September 2020 during the height of COVID restrictions when family couldn't accompany her to treatments. With 35 years of nursing experience and a role teaching future nurses at Liberty University, Carol brought professional knowledge to her patient experience that provided both advantages and surprising challenges.Her decision to join a clinical trial stands as perhaps the most fascinating aspect of this conversation. Despite her medical background, Carol experienced the vulnerability all patients feel when considering experimental treatments. The outcome? Extraordinary monitoring that included multiple echocardiograms, rapid tumor response, and a comprehensive team approach that left her feeling exceptionally well-cared for. "If I were to go through the whole thing again, I would jump into a clinical trial again, 100%," she reflects.Through chemotherapy, surgery, radiation, and even cognitive therapy for "chemo brain," Carol's journey spans numerous departments within Centra Health. Now three years post-treatment with regular follow-ups, she finds herself transformed. "I am such a better person on this side of cancer than I was beforehand," she reveals, describing a deeper faith, greater empathy, and profound perspective shift that turns even "bad hair days" into moments of gratitude. Her powerful closing message resonates for anyone facing difficult circumstances: "I can do hard things." Listen now to experience this remarkable story of professional insight meeting personal transformation.For more content from Centra Health check us out on the following channels.YouTubeFacebookInstagramTwitter

New Podcast Alert ‼️

“This sucks, and it's going to be hard, and this is very real. But that doesn't mean we're going to stop having fun along the way. So let's have fun when it feels right.” We're due for a catch-up. SPONSOR:  UCAN: Click here to get a FREE UCAN sample pack (you'll just pay the cost of shipping), and use code ALI for 20% off your entire UCAN order. Follow: Instagram @aliontherun1 Join the Facebook group Support on Patreon Subscribe to the newsletter SUPPORT: If you're enjoying the show, please subscribe and leave a rating and review on Apple Podcasts. And if you liked this episode, share it with your friends!

This episode is such an exciting one, and honestly, it might just change the way you think about what you eat—especially if you've ever felt confused or overwhelmed about what's “safe” or supportive after a breast cancer diagnosis. I'm talking about two powerful cellular processes that are important for us to understand: autophagy and angiogenesis. These are what researchers call hallmarks of cancer—but they're also incredible opportunities for healing. And the best part? You don't need to fast for days or eat perfectly to support them. You just need to make some smart, loving food and lifestyle choices—and I'll walk you through what those are. We'll talk about how to support your body's natural clean-up system (autophagy) and how to regulate the way your body builds blood vessels (angiogenesis)—all through everyday foods, simple habits, and ditching the all-or-nothing mindset.  

In this powerful episode of Keeping Abreast with Dr. Jenn, I'm joined by visionary functional medicine practitioner and thought leader, Teri Cochrane, for a deep and eye-opening conversation about bio-individuality—the truth that there is no one-size-fits-all when it comes to health.Teri shares her compelling personal journey that led her to create her unique approach to wellness, centered on genetics, pathogens, nutrition, and energy. Together, we explore the critical role of personalized medicine, especially in the wake of COVID-19 and the rising incidence of aggressive cancers in younger populations.We uncover the often-overlooked influence of pathogens, environmental shifts, and the evolving food supply on our biochemistry. Teri introduces us to the concept of epigenetic analysis and how understanding our individual genetic makeup can guide us in making precise, healing dietary and lifestyle choices.Whether you are navigating cancer, autoimmune illness, or simply trying to make sense of your body's signals, this conversation is filled with insight, validation, and empowerment.In This Episode, You Will Learn:Bio-individuality is the cornerstone of true health—what works for one may harm another.Conventional dietary guidelines often fail cancer patients.Pathogens, both viral and parasitic, play a significant role in chronic disease and cancer.COVID-19 has had a profound impact on our biochemical balance.Functional medicine and epigenetic testing provide a more complete picture of your health.Stress responses directly impact immune function and must be managed to heal.Understanding genetic variants can help tailor your nutrition for optimal wellness.Even foods labeled “healthy” may not be healthy for you.There is immense power in listening to your body's cues and honoring your unique needs.If you've ever felt like you're doing “all the right things” but still not feeling well, this episode may hold the answers you've been searching for. 

We asked what you struggle with the most when living with cancer and the fear of dying and overall anxiety always tops the list. In this episode we talk about learning to live with the fear and ways to counter it. Each week, Heather shares profound insights gained from her remarkable 25-year journey as a metastatic breast cancer survivor. Join us as we delve into essential topics like cancer survivorship, where Heather and Larry impart valuable mental health advice and coping strategies for cancer patients. From navigating hospitals to post-treatment tips, Heather's candid and compassionate narrative serves as a beacon of strength. Tune in for an intimate exploration of coping mechanisms, including Heather's personal journey insights, as she imparts wisdom on resilience, hope, and living life to the fullest despite the challenges of metastatic breast cancer. If you or a loved one is seeking authentic guidance, this podcast provides a wealth of information, ensuring that no one faces cancer alone. Check out our newly designed 5 to Thrive Guides at www.heatherjose.com/products. Follow Heather's Socials: Instagram: HeatherbjoseLinkedIn: ⁠ / heatherjose ⁠ Youtube: @ImStillHereCancer Little Pink Houses of Hope Provides Free Vacations for People with Breast Cancer- ⁠https://www.littlepink.org/⁠ ⁠#MetastaticBreastCancer⁠ ⁠#Fear⁠ ⁠#Deconstruction⁠ ⁠#CancerSurvivor⁠ ⁠#ThrivingWithCancer⁠ ⁠#MentalHealthMatters⁠ ⁠#NutritionForWellness⁠ ⁠#MedicalAdvancements⁠ ⁠#MindfulnessJourney⁠ ⁠#ResiliencePodcast⁠ ⁠#PatientAdvocacy⁠ ⁠#TreatmentInsights⁠ ⁠#SurvivorStories⁠ ⁠#PodcastHope⁠ ⁠#CommunitySupport⁠ ⁠#EmpowermentPodcast⁠ ⁠#LivingBeyondDiagnosis⁠ ⁠#PositiveMindset⁠ ⁠#WellnessWednesday⁠ ⁠#CancerAwareness